CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
2.560
+0.070 (2.81%)
Nov 21, 2024, 1:22 PM EST - Market open
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 16. The average target predicts an increase of 290.64% from the current stock price of 2.56.
Analyst Consensus: Hold
* Price targets were last updated on Sep 16, 2024.
Analyst Ratings
The average analyst rating for CureVac stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +525.02% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +525.02% | Aug 16, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +603.15% | Jul 3, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +56.26% | Apr 25, 2024 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 5, 2024 |
Financial Forecast
Revenue This Year
120.40M
from 53.76M
Increased by 123.97%
Revenue Next Year
60.13M
from 120.40M
Decreased by -50.06%
EPS This Year
-0.27
from -1.18
EPS Next Year
-0.42
from -0.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 460.6M | 139.7M | 154.1M | ||
| Avg | 120.4M | 60.1M | 130.8M | ||
| Low | n/a | n/a | 103.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 756.9% | 16.0% | 156.3% | ||
| Avg | 124.0% | -50.1% | 117.6% | ||
| Low | - | - | 72.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.62 | -0.11 | -0.11 | |
| Avg | -0.27 | -0.42 | -0.19 | |
| Low | -1.26 | -0.65 | -0.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.